It's always been a bit of a hard comparison but obviously they are both doing their thing where PYC talks in billions of peptides Peptidream talks in trillions they also have very fast way to screen & synthesise them with three technologies and at a very low cost - I guess PYC might be able to rival that if the chip is successfully built that allows them greatly increase the speed ? I think peptidream have 6 big pharma collaborations as well as smaller biotech and as far as I recall only one has walked ? last year ? I always thought PYC should of or still could I guess at a later date maybe - delist here stay off the radar for a year whilst still advancing then IPO overseas - always much better outcomes than dual listings where it needs to navigate or lead from more than one market. Part of the reason peptidream took off on IPO was because it had remained off the radar and out of grasps then when the listed they only offered about 20% of the company in the public offering.
PYC Price at posting:
1.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)